5433502025-07-012025-09-305433502025-09-305433502025-03-315433502025-04-012025-09-305433502025-07-012025-09-30in-capmkt:OtherExpenses1Member5433502025-04-012025-09-30in-capmkt:OtherExpenses1Member5433502025-07-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15433502025-04-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss1iso4217:INRxbrli:pureiso4217:INRxbrli:shares543350VIJAYANOTLISTEDINE043W01024VIJAYA DIAGNOSTIC CENTRE LIMITEDMain BoardEquity2025-04-012026-03-312025-11-042025-10-27INRLakhsQuarterlySecond quarterSingle segmentDiagnostic services2025-11-0413:00:002025-11-0414:15:00trueCash Flow IndirectNot applicable2025-07-012025-09-30UnauditedConsolidated2015618000624860002078104000243193000003225930007827200022267000063156300014982910005798130000579813000126315000206680001469830000432830000000043283000029560004357860004328300000435786000010272500014.214.2004.214.20001. The above consolidated financial results of Vijaya Diagnostic Centre Limited ("the Company") and its subsidiaries (the Company and its subsidiaries together referred to as "the Group") have been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standards ("Ind AS") prescribed under Section 133 of the Companies Act, 2013 ('the Act') read with the relevant rules thereunder, other accounting principles generally accepted in India and is in compliance with the presentation and disclosure requirements of Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, (as amended). <BR> 2. The above consolidated financial results were reviewed by the audit committee and approved by the Board of Directors in their respective meetings held on 04 November 2025. The statutory auditors have carried out limited review of the above results for the quarter and year-to-date ended 30 September 2025. An unmodified report has been issued by them thereon. <BR> 3. The Group has one reportable segment (viz. Diagnostic Services) as per the requirements of Ind AS 108 "Operating Segments". <BR> 4. During the previous year, the Company has incurred an amount of Rs. 102.96 towards acquisition/restructuring related costs. These expenses had been categorised as exceptional items as these are not incurred in the ordinary course of business of operations of the Company. <BR> 5. During the quarter and year-to-date ended 30 September 2025, the Company has issued 37,825 and 88,658 equity shares of face value of Re. 1/- each respectively on exercise of employee stock options. <BR> 6. The Board of Directors at its meeting held on May 12, 2025, has proposed and recommended dividend of Re. 2/- per equity share of Re. 1 each i.e., 200% for the financial year 2024-25, subject to the approval of the members at the ensuring annual general meeting. The same was approved by the shareholders in the Annual General Meeting of the Company held on 05 September 2025 and was paid on 12 September 2025. <BR> 7. The Company has received an approval from National Company Law Tribunal (“NCLT”), vide order dated 13 October 2025 for the proposed merger of Medinova Diagnostic Services Limited with the Company. The effect of the same has been given in these consolidated financial results. <BR> 8. The results of the Group are available for investors at www.vijayadiagnostic.com, www.nseindia.com and www.bseindia.com.2025-04-012025-09-30UnauditedConsolidated389614900013297000040291190004573200000063866400015312600043157100012465590002927240000110187900001101879000242278000408810002831590000818720000000081872000022390008209590008187200000820959000010272500017.967.95007.967.95000Other Expenses631563000Other Expenses124655900084338240004528740000119204900021320400000040000000167408000167808000024289600010702655000358210002286754000119479000242068000507590000389484000308854400007999400032043590001390701400010272500085480030008650728000086507280000000344650300034465030001079070009439400004222000365302600001443700038379800039823500010123800001410615000580200006634900068276000016032600000052562860001390701400015312600013506000201080000-10731200000-12967000066818000030413000043157100000078380000003555000011806000-345210000-57441000080000000495395000159727400000021074800001386526000000000000933495000156060000000000000036415900000000366390000405168000-8402410000000003198900000011867900020545100014008700000-4322280001140570000114057000128011000242068000Remeasurement of defined benefit liability / (asset)39500003950000Remeasurement of defined benefit liability / (asset)299200029920009940007530000029560002239000